title: Molecular composition of the intercalated disc in a spontaneous canine animal model of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
abstract: BACKGROUND
  Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is characterized by ventricular arrhythmias, sudden death, and fatty or fibrofatty replacement of right ventricular myocytes. Recent studies have noted an association between human ARVD/C and molecular remodeling of intercalated disc structures. However, progress has been constrained by limitations inherent to human studies.
  
  
  OBJECTIVE
  We studied the molecular composition of the intercalated disc structure in a naturally occurring animal model of ARVD/C (Boxer dogs).
  
  
  METHODS
  We studied hearts from 12 Boxers with confirmed ARVD/C and 2 controls. Ventricular sections from 4 animals were examined by immunofluorescent microscopy. Frozen tissue samples were used for Western blot analysis. Proteins investigated were N-cadherin, plakophilin 2, desmoplakin, plakoglobin, desmin, and connexin 43 (Cx43).
  
  
  RESULTS
  In control dogs, all proteins tested by immunofluorescence analysis yielded intense localized signals at sites of end-to-end cell apposition. In contrast, myocardial tissues from ARVD/C-afflicted Boxers showed preservation of N-cadherin staining but loss of detectable signal for Cx43 at the intercalated disc location. Western blots indicated that the Cx43 protein was still present in the samples. Gene sequencing analysis showed no mutations in desmoplakin, plakoglobin, Cx43, or plakophilin 2.
  
  
  CONCLUSIONS
  Mutation(s) responsible for ARVD/C in Boxers lead, directly or indirectly, to severe modifications of mechanical and electrical cell-cell interactions. Furthermore, significant reduction in gap junction formation may promote a substrate for malignant ventricular arrhythmias. This model may help to advance our understanding of the molecular basis, pathophysiology, and potential therapeutic approach to patients with ARVD/C.
authors.affiliation: Department of Pharmacology, SUNY Upstate Medical University, Syracuse, New York 13210, USA. oxforde@upstate.edu
authors.forename: Eva M
authors.initials: EM
authors.lastname: Oxford
authors.forename: Melanie
authors.initials: M
authors.lastname: Everitt
authors.forename: Wanda
authors.initials: W
authors.lastname: Coombs
authors.forename: Philip R
authors.initials: PR
authors.lastname: Fox
authors.forename: Marc
authors.initials: M
authors.lastname: Kraus
authors.forename: Anna R M
authors.initials: AR
authors.lastname: Gelzer
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Saffitz
authors.forename: Steven M
authors.initials: SM
authors.lastname: Taffet
authors.forename: N Sydney
authors.initials: NS
authors.lastname: Moïse
authors.forename: Mario
authors.initials: M
authors.lastname: Delmar
mesh_terms: D000818:Animals; D019571:Arrhythmogenic Right Ventricular Dysplasia / Q000235:genetics*; D015153:Blotting, Western / Q000379:methods; D015820:Cadherins / Q000235:genetics*; D018031:Connexin 43 / Q000235:genetics*; D003598:Cytoskeletal Proteins / Q000235:genetics; D004195:Disease Models, Animal; D004285:Dogs; D005260:Female; D017629:Gap Junctions / Q000737:chemistry / Q000235:genetics; D008297:Male; D009154:Mutation; D032383:Myocytes, Cardiac / Q000737:chemistry* / Q000473:pathology / Q000648:ultrastructure; D017422:Sequence Analysis, DNA
chemical_list: D015820:Cadherins; D018031:Connexin 43; D003598:Cytoskeletal Proteins